Literature DB >> 19365187

Reconciling neuroimaging and neuropathological findings in schizophrenia and bipolar disorder.

Alex Fornito1, Murat Yücel, Christos Pantelis.   

Abstract

PURPOSE OF REVIEW: Although structural magnetic resonance imaging (sMRI) and neuropathological investigations offer complementary information that can be used to formulate and test hypotheses about pathophysiological mechanisms in psychiatric disorders, the findings from these two fields are seldom integrated in a systematic manner. In this study, we overview recent sMRI findings in schizophrenia and bipolar disorder and consider how they relate to neuropathological data. RECENT
FINDINGS: sMRI research indicates that schizophrenia is associated with volumetric reductions in a network of frontal, temporal, limbic, striatal, and thalamic regions. Some of these abnormalities are apparent prior to psychosis onset and may progress with ongoing illness. sMRI findings in bipolar disorder have been more variable, with both volumetric increases and decreases being reported across several brain regions at different illness stages. Neuropathological studies of both patient groups suggest the cellular changes associated with these volumetric differences affect diverse tissue compartments in a regionally heterogeneous way.
SUMMARY: These findings suggest that any putative pathophysiological mechanism in schizophrenia or bipolar disorder should account for the dynamic, complex, and regionally heterogeneous brain abnormalities seen in these patients. We contend that greater integration of the findings from these two fields will facilitate more targeted and hypothesis-driven research in the future.

Entities:  

Mesh:

Year:  2009        PMID: 19365187     DOI: 10.1097/YCO.0b013e32832a1353

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  15 in total

1.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

Review 2.  Role of estrogen treatment in the management of schizophrenia.

Authors:  Jayashri Kulkarni; Emmy Gavrilidis; Roisin Worsley; Emily Hayes
Journal:  CNS Drugs       Date:  2012-07-01       Impact factor: 5.749

Review 3.  Brain networks in schizophrenia.

Authors:  Martijn P van den Heuvel; Alex Fornito
Journal:  Neuropsychol Rev       Date:  2014-02-06       Impact factor: 7.444

4.  Mapping corticocortical structural integrity in schizophrenia and effects of genetic liability.

Authors:  Owen R Phillips; Keith H Nuechterlein; Robert F Asarnow; Kristi A Clark; Ryan Cabeen; Yaling Yang; Roger P Woods; Arthur W Toga; Katherine L Narr
Journal:  Biol Psychiatry       Date:  2011-05-14       Impact factor: 13.382

5.  Disease and genetic contributions toward local tissue volume disturbances in schizophrenia: a tensor-based morphometry study.

Authors:  Yaling Yang; Keith H Nuechterlein; Owen R Phillips; Boris Gutman; Florian Kurth; Ivo Dinov; Paul M Thompson; Robert F Asarnow; Arthur W Toga; Katherine L Narr
Journal:  Hum Brain Mapp       Date:  2012-09       Impact factor: 5.038

6.  ERBB4 polymorphism and family history of psychiatric disorders on age-related cortical changes in healthy children.

Authors:  Vanessa Douet; Linda Chang; Kristin Lee; Thomas Ernst
Journal:  Brain Imaging Behav       Date:  2015-03       Impact factor: 3.978

7.  Neuroimaging in the field of psychoses.

Authors:  Saxby Pridmore; Georgina Bowe
Journal:  Malays J Med Sci       Date:  2011-01

8.  Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.

Authors:  Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Journal:  Schizophr Res       Date:  2010-05-31       Impact factor: 4.939

9.  Discriminating schizophrenia and bipolar disorder by fusing fMRI and DTI in a multimodal CCA+ joint ICA model.

Authors:  Jing Sui; Godfrey Pearlson; Arvind Caprihan; Tülay Adali; Kent A Kiehl; Jingyu Liu; Jeremy Yamamoto; Vince D Calhoun
Journal:  Neuroimage       Date:  2011-05-27       Impact factor: 6.556

Review 10.  Biomarkers of bipolar disorder: specific or shared with schizophrenia?

Authors:  Frank Bellivier; Pierre Alexis Geoffroy; Jan Scott; Franck Schurhoff; Marion Leboyer; Bruno Etain
Journal:  Front Biosci (Elite Ed)       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.